4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-023061
EVP, Research & CSO sold 7,900 shares at $53.60 ($423,408)
- EVP, Research & CSO acquired 7,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-23 | Exercise or conversion : show line 1 in the form | +7,900 | $1.53 | $12,087 | 82,100 | D |
| 2021-03-23 | Sale : show line 2 in the form | −7,900 | $53.60 | $423,408 | 74,200 | D |
| Open-market sales · 7,900 sh · avg $53.60 · $423,408 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-23 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −7,900 | 337,555 | D |
Loading xslF345X03/doc4.xml…